Term ended Oct 6, 2026 · Medium confidence
20-year base term ended Oct 6, 2026
Why Medium: A parent in the chain could not be resolved.
Held by Apellis Pharmaceuticals, Inc.
Filed Jan 6, 2017 as application 15/400,831 · Granted Sep 10, 2019
Base term, 20 years from filing
Today
Term ended Oct 6, 2026
2006
2026
Clock starts
Oct 6, 2006
Oct 6, 2006
Term ended
Oct 6, 2026
Oct 6, 2026
Granted
Sep 10, 2019
Sep 10, 2019
base term
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 6, 2006, when application 11/544,389, the earliest non-provisional in its chain, was filed (this one was filed Jan 6, 2017); a parent in its chain could not be resolved (the next row) | Oct 6, 2026 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Oct 6, 2026 | Medium confidence |
This family
| US 8,168,584 | In force Apr 2027 | Apr 2027 |
| US 9,056,076 | Term ended no later than Oct 2026 | no later than Oct 2026 |
| Application 14/705,592 | Abandoned not computed | not computed |
| Application 14/744,019 | Abandoned not computed | not computed |
| US 10,407,466 | this patent Oct 2026 | Oct 2026 |
5 of 7 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 27, 2017 Reel 41099, frame 855 | Potentia Pharmaceuticals, Inc. | Apellis Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jan 27, 2017 Reel 41517, frame 594 | Deschatelets, Pascal; Olson, Paul; Francois, Cedric | Potentia Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| May 13, 2024 Reel 67398, frame 261 | Apellis Pharmaceuticals, Inc. | Sixth Street Lending Partners | Security Interest |
| May 15, 2026 Reel 75652, frame 212 | Sixth Street Lending Partners, in Its Capacity as Administrative Agent | Apellis Pharmaceuticals, Inc. | Release of Patent Security Agreement Recorded at Reel 067398 and Frame 0261 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
21
later US patents cite this one
That is top 25% of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.